Ramy Abdelnaby: Exploring The Timing of Antiplatelet Administration In Minor Stroke Post-Thrombolysis
Ramy Abdelnaby, Consultant Neurologist / Oberarzt at RWTH Aachen University Hospital, shared on LinkedIn about a recent article by Hui-Sheng Chen et al, published in European Heart Journal:
”Exploring the timing of antiplatelet administration in minor stroke post-thrombolysis, the EAST trial offers a comprehensive insight.
Conducted across multiple centers in China, this double-blind, randomized study evaluated the efficacy and safety of early antiplatelet treatment within 6 hours of intravenous thrombolysis in patients with mild neurological deficits.
Despite the high expectations, the trial concluded there’s no significant difference in achieving excellent functional outcomes at 90 days between the early treatment group and placebo.
This challenges existing paradigms and emphasizes the need for cautious decision-making in early antiplatelet therapy.”
Title: Early antiplatelet treatment for minor stroke following thrombolysis: the EAST trial
Authors: Hui-Sheng Chen, Yu Cui, Xiao-Qiu Li, Xin-Hong Wang, Chang-Hao Jiang, Jing Li, Zhi-Mei Yuan, Li-Wei Zhao, Nan Kong, Hai-Ning Mi, Jiang Lu, Hong Zhang, You-Jun Liu, Er-Qiang Wang, Yan Yang, Cheng-Guang Song, Yi Zhang, Shu-Yao Wang, Hong-Guo Dai, Yi Yang, Shi-Mei Geng, Rong Yin, Duo-Lao Wang, Thanh N. Nguyen
Read the Full Article on European Heart Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis